Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CERMEP (Centre d'Exploration et de Recherche Multimodal et Pluridisciplinaire) is a leading multimodal imaging center based in Lyon, France, specializing in both clinical and preclinical research. As a multidisciplinary platform, it offers a comprehensive suite of imaging technologies, including PET, MRI, MEG, and CT, supported by an on-site radiochemistry facility and cyclotrons. The center operates as a Groupement d'Intérêt Économique (GIE), bringing together major French research institutions and hospital networks to advance medical diagnostics and therapeutic monitoring. CERMEP is particularly recognized for its expertise in neuroimaging and the development of novel radiotracers under GMP conditions. It provides essential services to academic researchers and pharmaceutical companies for drug discovery and validation across various therapeutic areas, including neurology, oncology, and cardiology. Its integrated approach allows for seamless translation from preclinical models to clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CERMEP.